Skip to main content

Competition Authority Sources Say Faulty Presentations Shifted Cal Sale Review

Sources close to the Israel Competition Authority said staff gave favorable early indications for Discount Bank's planned sale of Cal after evaluating the parties' proposed remedies and representations, but later checks found parts of those representations inaccurate. The newly disclosed account describes a shift in the review before the authority imposed a condition requiring purchaser Union Investments to divest its Super-Pharm stake. Discount Bank's September 23 filing says the purchasers stated that the agreement would be canceled when its November 1 extension ends if the condition remains, with the sellers entitled to NIS 187 million in compensation. Sources close to Discount Bank said they fear possible investor claims over the buyer selection.

Add Your Voice

Sources

Israel Discount BankSource Language: EnglishOpens in a new tab.Secondary sources:1
Courtroom-sketch editorial illustration of a Discount Bank branch interior photographed in August 2018; archival context, not a depiction of the Cal sale or Competition Authority review.

Commentary

Add Your Voice
Loading comments…

Related articles

  1. Bank of Israel Rejects NIS 200 Withdrawal as Tax Chief Revives Cash Restrictions
  2. Leumi CEO Pledges Digital Account Opening for Small Companies by End of 2026
  3. Discount and Mercantile Boards Approve Bank Merger
  4. Officials Reportedly Open to Extending Discount Bank's Cal Sale Deadline
  5. NIS 4 Billion CAL Sale Collapses After Horesh Rejects Super-Pharm Condition

Voices

Write about thisPost a clip

Something went wrong

We couldn't complete that action. Check your connection and try again.